Ceramide AP

Ceramide AP is a lipid of Sphingolipids (SP) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 96 references associated with Ceramide AP in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Ceramide AP

Download all related citations
Per page 10 20 | Total 18
Authors Title Published Journal PubMed Link
pmid:
Gong T et al. Endoplasmic reticulum (ER) stress inhibitor salubrinal protects against ceramide-induced SH-SY5Y cell death. 2012 Biochem. Biophys. Res. Commun. pmid:22935424
Jiang Y et al. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. 2011 Cancer Biol. Ther. pmid:21795855
Chen MB et al. C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling. 2015 Carcinogenesis pmid:26116623
Zhou Y et al. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development. 2016 Cell. Physiol. Biochem. pmid:27512981
Raudenkolb S et al. Polymorphism of ceramide 6: a vibrational spectroscopic and X-ray powder diffraction investigation of the diastereomers of N-(alpha-hydroxyoctadecanoyl)-phytosphingosine. 2005 Chem. Phys. Lipids pmid:15589229
Ryabova NY et al. Investigation of stratum corneum lipid model membranes with free fatty acid composition by neutron diffraction. 2010 Eur. Biophys. J. pmid:20012954
Kaushik D et al. Percutaneous penetration modifiers and formulation effects. 2010 Int J Pharm pmid:19900521
Devalapally H et al. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. 2007 Int. J. Cancer pmid:17557285
Chapman JV et al. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity. 2010 Int. J. Oncol. pmid:21042729

Table of Content